Fanconi Anemia Complementation Group W C4521564
A subtype of Fanconi anemia affecting DNA repair. It can cause bone marrow failure, physical anomalies, and higher cancer risk. Management involves supportive therapy and potential stem cell transplant.
Key facts at a glance
- ICD-10
- D61.03
- ICD-11
- 3A00.0
- Body system
- hematologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Anemia-related fatigue
(hematologic)Generalized symptoms
(hematologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Petechiae
(hematologic)Neutropenia-related infections
(hematologic)Congenital heart defects
(hematologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Hematopoietic Stem Cell Transplantation
Definitive curative approach for hematopoietic failure in Fanconi anemia complementation group W. Requires FA-specific conditioning protocols with reduced toxicity to prevent excessive organ damage in these patients.
Supportive Pharmacotherapy
Includes androgens for cytopenias, growth factors for neutropenia, and appropriate antimicrobial prophylaxis. Treatment tailored to specific hematologic deficits present in each patient.
Additional treatment options
Multisystem Organ Surveillance
Regular assessment of renal function, cardiac status, and endocrine function given reported congenital abnormalities in FA-W patients. Includes echocardiography, renal ultrasound, and endocrine panels.
monitoringBlood Component Therapy
Chronic transfusion support for symptomatic anemia and thrombocytopenia when endogenous hematopoiesis is insufficient. Use of leukoreduced and irradiated products to minimize complications.
procedureRenal-PROTECTIVE Diet
Dietary modifications to support kidney function including appropriate protein intake, sodium restriction, and hydration. Consultation with renal dietitian recommended for optimal management.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Fanconi Anemia Complementation Group W C4521564?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Fanconi Anemia Complementation Group W C4521564. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy